Clinical Trial Detail

NCT ID NCT01585415
Title Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

melanoma

Therapies

Vandetanib

Age Groups: adult

Additional content available in CKB BOOST